List of Tables
Table 1. Global Virtual Screening for Drug Discovery Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Virtual Screening for Drug Discovery Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Virtual Screening for Drug Discovery Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Virtual Screening for Drug Discovery Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Virtual Screening for Drug Discovery Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Virtual Screening for Drug Discovery Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Virtual Screening for Drug Discovery Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Virtual Screening for Drug Discovery by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virtual Screening for Drug Discovery as of 2024)
Table 11. Global Virtual Screening for Drug Discovery Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Virtual Screening for Drug Discovery Companies Headquarters
Table 13. Global Virtual Screening for Drug Discovery Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Virtual Screening for Drug Discovery Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Virtual Screening for Drug Discovery Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Virtual Screening for Drug Discovery Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Virtual Screening for Drug Discovery Revenue by Application (2026-2031) & (US$ Million)
Table 21. Virtual Screening for Drug Discovery High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Virtual Screening for Drug Discovery Growth Accelerators and Market Barriers
Table 25. North America Virtual Screening for Drug Discovery Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Virtual Screening for Drug Discovery Growth Accelerators and Market Barriers
Table 27. Europe Virtual Screening for Drug Discovery Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Virtual Screening for Drug Discovery Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Virtual Screening for Drug Discovery Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Virtual Screening for Drug Discovery Investment Opportunities and Key Challenges
Table 31. Central and South America Virtual Screening for Drug Discovery Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Virtual Screening for Drug Discovery Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Virtual Screening for Drug Discovery Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. MedChemExpress Corporation Information
Table 35. MedChemExpress Description and Major Businesses
Table 36. MedChemExpress Product Features and Attributes
Table 37. MedChemExpress Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. MedChemExpress Revenue Proportion by Product in 2024
Table 39. MedChemExpress Revenue Proportion by Application in 2024
Table 40. MedChemExpress Revenue Proportion by Geographic Area in 2024
Table 41. MedChemExpress Virtual Screening for Drug Discovery SWOT Analysis
Table 42. MedChemExpress Recent Developments
Table 43. TargetMol Corporation Information
Table 44. TargetMol Description and Major Businesses
Table 45. TargetMol Product Features and Attributes
Table 46. TargetMol Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. TargetMol Revenue Proportion by Product in 2024
Table 48. TargetMol Revenue Proportion by Application in 2024
Table 49. TargetMol Revenue Proportion by Geographic Area in 2024
Table 50. TargetMol Virtual Screening for Drug Discovery SWOT Analysis
Table 51. TargetMol Recent Developments
Table 52. OpenEye Scientific Corporation Information
Table 53. OpenEye Scientific Description and Major Businesses
Table 54. OpenEye Scientific Product Features and Attributes
Table 55. OpenEye Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. OpenEye Scientific Revenue Proportion by Product in 2024
Table 57. OpenEye Scientific Revenue Proportion by Application in 2024
Table 58. OpenEye Scientific Revenue Proportion by Geographic Area in 2024
Table 59. OpenEye Scientific Virtual Screening for Drug Discovery SWOT Analysis
Table 60. OpenEye Scientific Recent Developments
Table 61. Eurofins Discovery Corporation Information
Table 62. Eurofins Discovery Description and Major Businesses
Table 63. Eurofins Discovery Product Features and Attributes
Table 64. Eurofins Discovery Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Eurofins Discovery Revenue Proportion by Product in 2024
Table 66. Eurofins Discovery Revenue Proportion by Application in 2024
Table 67. Eurofins Discovery Revenue Proportion by Geographic Area in 2024
Table 68. Eurofins Discovery Virtual Screening for Drug Discovery SWOT Analysis
Table 69. Eurofins Discovery Recent Developments
Table 70. Sygnature Discovery Corporation Information
Table 71. Sygnature Discovery Description and Major Businesses
Table 72. Sygnature Discovery Product Features and Attributes
Table 73. Sygnature Discovery Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Sygnature Discovery Revenue Proportion by Product in 2024
Table 75. Sygnature Discovery Revenue Proportion by Application in 2024
Table 76. Sygnature Discovery Revenue Proportion by Geographic Area in 2024
Table 77. Sygnature Discovery Virtual Screening for Drug Discovery SWOT Analysis
Table 78. Sygnature Discovery Recent Developments
Table 79. Jubilant Biosys Corporation Information
Table 80. Jubilant Biosys Description and Major Businesses
Table 81. Jubilant Biosys Product Features and Attributes
Table 82. Jubilant Biosys Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Jubilant Biosys Recent Developments
Table 84. Schrödinger, Inc. Corporation Information
Table 85. Schrödinger, Inc. Description and Major Businesses
Table 86. Schrödinger, Inc. Product Features and Attributes
Table 87. Schrödinger, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Schrödinger, Inc. Recent Developments
Table 89. Cresset Group Corporation Information
Table 90. Cresset Group Description and Major Businesses
Table 91. Cresset Group Product Features and Attributes
Table 92. Cresset Group Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Cresset Group Recent Developments
Table 94. ComputaBio Corporation Information
Table 95. ComputaBio Description and Major Businesses
Table 96. ComputaBio Product Features and Attributes
Table 97. ComputaBio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. ComputaBio Recent Developments
Table 99. Profacgen Corporation Information
Table 100. Profacgen Description and Major Businesses
Table 101. Profacgen Product Features and Attributes
Table 102. Profacgen Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Profacgen Recent Developments
Table 104. CD ComputaBio Corporation Information
Table 105. CD ComputaBio Description and Major Businesses
Table 106. CD ComputaBio Product Features and Attributes
Table 107. CD ComputaBio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. CD ComputaBio Recent Developments
Table 109. Creative Biolabs Corporation Information
Table 110. Creative Biolabs Description and Major Businesses
Table 111. Creative Biolabs Product Features and Attributes
Table 112. Creative Biolabs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Creative Biolabs Recent Developments
Table 114. BOC Sciences Corporation Information
Table 115. BOC Sciences Description and Major Businesses
Table 116. BOC Sciences Product Features and Attributes
Table 117. BOC Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. BOC Sciences Recent Developments
Table 119. CKTTDB Corporation Information
Table 120. CKTTDB Description and Major Businesses
Table 121. CKTTDB Product Features and Attributes
Table 122. CKTTDB Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. CKTTDB Recent Developments
Table 124. HitGen Corporation Information
Table 125. HitGen Description and Major Businesses
Table 126. HitGen Product Features and Attributes
Table 127. HitGen Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. HitGen Recent Developments
Table 129. WuXi AppTec Corporation Information
Table 130. WuXi AppTec Description and Major Businesses
Table 131. WuXi AppTec Product Features and Attributes
Table 132. WuXi AppTec Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. WuXi AppTec Recent Developments
Table 134. LeadBuilder Corporation Information
Table 135. LeadBuilder Description and Major Businesses
Table 136. LeadBuilder Product Features and Attributes
Table 137. LeadBuilder Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. LeadBuilder Recent Developments
Table 139. CSNpharm Corporation Information
Table 140. CSNpharm Description and Major Businesses
Table 141. CSNpharm Product Features and Attributes
Table 142. CSNpharm Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. CSNpharm Recent Developments
Table 144. ChemNavigator Corporation Information
Table 145. ChemNavigator Description and Major Businesses
Table 146. ChemNavigator Product Features and Attributes
Table 147. ChemNavigator Revenue (US$ Million) and Gross Margin (2020-2025)
Table 148. ChemNavigator Recent Developments
Table 149. Raw Materials Key Suppliers
Table 150. Distributors List
Table 151. Market Trends and Market Evolution
Table 152. Market Drivers and Opportunities
Table 153. Market Challenges, Risks, and Restraints
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Virtual Screening for Drug Discovery Product Picture
Figure 2. Global Virtual Screening for Drug Discovery Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Structure-based Virtual Screening (SBVS) Product Picture
Figure 4. Ligand-based Virtual Screening (LBVS) Product Picture
Figure 5. Hybrid Methods Product Picture
Figure 6. Global Virtual Screening for Drug Discovery Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Pharmaceutical Company
Figure 8. Universities and Research Institutions
Figure 9. Others
Figure 10. Virtual Screening for Drug Discovery Report Years Considered
Figure 11. Global Virtual Screening for Drug Discovery Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Virtual Screening for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 13. Global Virtual Screening for Drug Discovery Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Virtual Screening for Drug Discovery Revenue Market Share by Region (2020-2031)
Figure 15. Global Virtual Screening for Drug Discovery Revenue Market Share Ranking (2024)
Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 17. Structure-based Virtual Screening (SBVS) Revenue Market Share by Player in 2024
Figure 18. Ligand-based Virtual Screening (LBVS) Revenue Market Share by Player in 2024
Figure 19. Hybrid Methods Revenue Market Share by Player in 2024
Figure 20. Global Virtual Screening for Drug Discovery Revenue Market Share by Type (2020-2031)
Figure 21. Global Virtual Screening for Drug Discovery Revenue Market Share by Application (2020-2031)
Figure 22. North America Virtual Screening for Drug Discovery Revenue YoY (2020-2031) & (US$ Million)
Figure 23. North America Top 5 Players Virtual Screening for Drug Discovery Revenue (US$ Million) in 2024
Figure 24. North America Virtual Screening for Drug Discovery Revenue (US$ Million) by Type (2020 - 2031)
Figure 25. North America Virtual Screening for Drug Discovery Revenue (US$ Million) by Application (2020-2031)
Figure 26. US Virtual Screening for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 27. Canada Virtual Screening for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 28. Mexico Virtual Screening for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 29. Europe Virtual Screening for Drug Discovery Revenue YoY (2020-2031) & (US$ Million)
Figure 30. Europe Top 5 Players Virtual Screening for Drug Discovery Revenue (US$ Million) in 2024
Figure 31. Europe Virtual Screening for Drug Discovery Revenue (US$ Million) by Type (2020-2031)
Figure 32. Europe Virtual Screening for Drug Discovery Revenue (US$ Million) by Application (2020-2031)
Figure 33. Germany Virtual Screening for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 34. France Virtual Screening for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 35. U.K. Virtual Screening for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 36. Italy Virtual Screening for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 37. Russia Virtual Screening for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Virtual Screening for Drug Discovery Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Top 8 Players Virtual Screening for Drug Discovery Revenue (US$ Million) in 2024
Figure 40. Asia-Pacific Virtual Screening for Drug Discovery Revenue (US$ Million) by Type (2020-2031)
Figure 41. Asia-Pacific Virtual Screening for Drug Discovery Revenue (US$ Million) by Application (2020-2031)
Figure 42. Indonesia Virtual Screening for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 43. Japan Virtual Screening for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 44. South Korea Virtual Screening for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 45. Australia Virtual Screening for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 46. India Virtual Screening for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 47. Indonesia Virtual Screening for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 48. Vietnam Virtual Screening for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 49. Malaysia Virtual Screening for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 50. Philippines Virtual Screening for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 51. Singapore Virtual Screening for Drug Discovery Revenue (2020-2031) & (US$ Million)
Figure 52. Central and South America Virtual Screening for Drug Discovery Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Central and South America Top 5 Players Virtual Screening for Drug Discovery Revenue (US$ Million) in 2024
Figure 54. Central and South America Virtual Screening for Drug Discovery Revenue (US$ Million) by Type (2020-2031)
Figure 55. Central and South America Virtual Screening for Drug Discovery Revenue (US$ Million) by Application (2020-2031)
Figure 56. Brazil Virtual Screening for Drug Discovery Revenue (2020-2025) & (US$ Million)
Figure 57. Argentina Virtual Screening for Drug Discovery Revenue (2020-2025) & (US$ Million)
Figure 58. Middle East and Africa Virtual Screening for Drug Discovery Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Middle East and Africa Top 5 Players Virtual Screening for Drug Discovery Revenue (US$ Million) in 2024
Figure 60. South America Virtual Screening for Drug Discovery Revenue (US$ Million) by Type (2020-2031)
Figure 61. Middle East and Africa Virtual Screening for Drug Discovery Revenue (US$ Million) by Application (2020-2031)
Figure 62. GCC Countries Virtual Screening for Drug Discovery Revenue (2020-2025) & (US$ Million)
Figure 63. Israel Virtual Screening for Drug Discovery Revenue (2020-2025) & (US$ Million)
Figure 64. Egypt Virtual Screening for Drug Discovery Revenue (2020-2025) & (US$ Million)
Figure 65. South Africa Virtual Screening for Drug Discovery Revenue (2020-2025) & (US$ Million)
Figure 66. Virtual Screening for Drug Discovery Industry Chain Mapping
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
